References
- Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology50, 1282–1293 (2009).
- Schwimmer J, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics118, 1388–1393 (2006).
- Schwimmer J, Behling C, Newbury R, Deutsch R, Schork N, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology42, 641–649 (2005).
- Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut58, 1538–1544 (2009).
- Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation118, 277–283 (2008).
- Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J. Pediatr.136, 734–738 (2000).
- Schwimmer JB, Middleton M, Deutsch R, Lavine JE. A Phase 2 clinical trial of metformin as a treatment for non-diabetic pediatric nonalcoholic steatohepatitis. Aliment Pharmacol. Ther.21, 871–879 (2005).
- Dohil R, Schmeltzer S, Cabrera B et al. Pilot study: enteric-coated cysteamine for the treatment of pediatric nonalcoholic fatty liver disease. Aliment Pharmacol. Ther.33, 1036–1044 (2011).
- Nobili V, Manco M, Devito R et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology48, 119–128 (2008).
- Day CP, James OF. Steatohepatitis: a tale of two ‘hits’? Gastroenterology114, 8424–8445 (1998).
- Patton HM, Lavine JE, Van Natta ML et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis (NASH). Gastroenterology135, 1961–1971 (2008).
- Lavine JE, Schwimmer JB, Molleston JP et al. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp. Clin. Trials31, 62–70 (2010).
- Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histologic scoring system for nonalcoholic fatty liver disease. Hepatology41, 1313–1321 (2005).
- Lavine JE, Schwimmer JB, Van Natta ML et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA305(16), 1659–1668 (2011).
- Sanyal AJ, Chalasani N, Kowdley K et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med.362, 1675–1685 (2010).
- Sanyal AJ, Brunt EM, Kleiner DE et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology54(1), 344–353 (2011).